Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders

被引:33
作者
Bashashati, Mohammad [1 ]
McCallum, Richard W. [2 ]
机构
[1] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada
[2] Texas Tech Univ, Dept Internal Med, El Paso, TX USA
关键词
Nausea; Vomiting; Cyclic vomiting syndrome; Treatment; Physiopathology; CHEMOTHERAPY-INDUCED NAUSEA; IRRITABLE-BOWEL-SYNDROME; NEUROKININ-1 RECEPTOR ANTAGONISTS; ORAL CLONIDINE PREMEDICATION; STIMULATES GASTRIC-MOTILITY; VAGAL AFFERENT NEURONS; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL DYSPEPSIA; AREA POSTREMA; POSTOPERATIVE NAUSEA;
D O I
10.1016/j.ejphar.2013.09.075
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nausea and vomiting are common gastrointestinal complaints which could be triggered by stimuli in both the peripheral and central nervous systems. They may be considered as defense mechanisms when threatening toxins/agents enter the gastrointestinal tract or there is excessive retention of gastrointestinal contents due to obstruction. The pathophysiology of nausea and vomiting is complex and much still remains unknown. Therefore, treatments are restricted or ineffective in many cases. Nausea and vomiting with functional etiologies including cyclic vomiting syndrome are challenging in gastroenterology. In this article, we review potential pathways, neurochemical transmitters, and their receptors which are possibly involved in the pathophysiology of nausea and vomiting including the entity cyclic vomiting syndrome. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:79 / 94
页数:16
相关论文
共 192 条
[1]   The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility [J].
Abalo, Raquel ;
Vera, Gema ;
Lopez-Perez, Ana Esther ;
Martinez-Villaluenga, Maria ;
Martin-Fontelles, Maria Isabel .
PHARMACOLOGY, 2012, 90 (1-2) :1-10
[2]   Cyclic vomiting syndrome in adults [J].
Abell, T. L. ;
Adams, K. A. ;
Boles, R. G. ;
Bousvaros, A. ;
Chong, S. K. F. ;
Fleisher, D. R. ;
Hasler, W. L. ;
Hyman, P. E. ;
Issenman, R. M. ;
Li, B. U. K. ;
Linder, S. L. ;
Mayer, E. A. ;
McCallum, R. W. ;
Olden, K. ;
Parkman, H. P. ;
Rudolph, C. D. ;
Tache, Y. ;
Tarbell, S. ;
Vakil, N. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (04) :269-284
[3]   Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats [J].
Adelson, David W. ;
Kosoyan, Hovsep P. ;
Wang, Yuhua ;
Steinberg, Justin Z. ;
Tache, Yvette .
JOURNAL OF NEUROPHYSIOLOGY, 2007, 97 (04) :3004-3014
[4]   Ghrelin, acylated ghrelin, leptin and PYY-3 levels in hyperemesis gravidarum [J].
Albayrak, Mustafa ;
Karatas, Ahmet ;
Demiraran, Yavuz ;
Erman, Hayriye ;
Topuz, Seren ;
Biyik, Ismail ;
Uzun, Hafize ;
Erkan, Muserref .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (09) :866-870
[5]  
Alizadeh R, 2012, IRAN J PEDIATR, V22, P399
[6]   Endocannabinoid control of gastric sensorimotor function in man [J].
Ameloot, K. ;
Janssen, P. ;
Scarpellini, E. ;
Vos, R. ;
Boesmans, W. ;
Depoortere, I. ;
Vanden Berghe, P. ;
Tack, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (10) :1123-1131
[7]   Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases [J].
Andrews, Paul L. R. ;
Horn, Charles C. .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2006, 125 (1-2) :100-115
[8]   RESINFERATOXIN, AN ULTRAPOTENT CAPSAICIN ANALOG, HAS ANTIEMETIC PROPERTIES IN THE FERRET [J].
ANDREWS, PLR ;
BHANDARI, P .
NEUROPHARMACOLOGY, 1993, 32 (08) :799-806
[9]   Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction [J].
Andrews, PLR ;
Sanger, GJ .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (06) :650-656
[10]   SYSTEMIC BACLOFEN STIMULATES GASTRIC-MOTILITY AND SECRETION VIA A CENTRAL ACTION IN THE RAT [J].
ANDREWS, PLR ;
WOOD, KL .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (03) :461-467